Salus reports lower H1 profit on higher revenue
Ljubljana, 12 August - Salus, the Ljubljana-based pharmaceutical wholesaler, generated EUR 247 million in sales revenue in the first half of the year, an increase of 14% on the same period a year ago. Net profit was down by 13% to EUR 6.4 million, which the company linked to a successfully settled lawsuit against a pharmacy in receivership.
The rest of this news item is available to subscribers.
The news item consists of 695 characters (without spaces) or 142 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.